A detailed history of Teacher Retirement System Of Texas transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 17,545 shares of BEAM stock, worth $508,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,545
Previous 15,243 15.1%
Holding current value
$508,980
Previous $357,000 20.17%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$22.57 - $33.14 $51,956 - $76,288
2,302 Added 15.1%
17,545 $429,000
Q2 2024

Aug 09, 2024

SELL
$21.22 - $32.66 $3,734 - $5,748
-176 Reduced 1.14%
15,243 $357,000
Q1 2024

May 06, 2024

SELL
$23.46 - $45.07 $1,102 - $2,118
-47 Reduced 0.3%
15,419 $509,000
Q4 2023

Feb 07, 2024

SELL
$17.69 - $30.76 $52,220 - $90,803
-2,952 Reduced 16.03%
15,466 $421,000
Q3 2023

Oct 31, 2023

BUY
$23.01 - $32.46 $62,334 - $87,934
2,709 Added 17.24%
18,418 $443,000
Q2 2023

Jul 19, 2023

SELL
$29.32 - $35.99 $48,612 - $59,671
-1,658 Reduced 9.55%
15,709 $502,000
Q1 2023

May 12, 2023

BUY
$30.15 - $48.79 $8,442 - $13,661
280 Added 1.64%
17,367 $532,000
Q4 2022

Feb 10, 2023

SELL
$36.73 - $51.6 $49,254 - $69,195
-1,341 Reduced 7.28%
17,087 $668,000
Q3 2022

Nov 03, 2022

BUY
$39.79 - $70.31 $385,206 - $680,671
9,681 Added 110.68%
18,428 $878,000
Q2 2022

Aug 09, 2022

BUY
$29.86 - $62.36 $51,359 - $107,259
1,720 Added 24.48%
8,747 $339,000
Q1 2022

May 09, 2022

BUY
$53.73 - $82.16 $36,805 - $56,279
685 Added 10.8%
7,027 $403,000
Q4 2021

Feb 10, 2022

BUY
$68.02 - $99.06 $96,044 - $139,872
1,412 Added 28.64%
6,342 $505,000
Q3 2021

Nov 09, 2021

BUY
$84.37 - $133.6 $81,417 - $128,924
965 Added 24.34%
4,930 $429,000
Q2 2021

Aug 05, 2021

BUY
$64.12 - $128.71 $254,235 - $510,335
3,965 New
3,965 $510,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.